Company news

NeoGenomics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

NeoGenomics Appoints Warren Stone as President & Chief Operating Officer

March 17, 2025

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

March 9, 2025

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

February 17, 2025

PacBio Announces Appointment of Chris Smith to Board of Directors

January 29, 2025

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

January 28, 2025

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

January 14, 2025

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

January 13, 2025

NeoGenomics Announces Chief Executive Officer Succession

January 9, 2025

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

January 5, 2025

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

December 10, 2024

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

December 8, 2024

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research

December 4, 2024

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

November 18, 2024

Felicia Williams Joins NeoGenomics Board of Directors

November 13, 2024

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

November 7, 2024

NeoGenomics Reports Third Quarter 2024 Results

November 4, 2024

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

October 21, 2024

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

October 14, 2024

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

October 7, 2024

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

September 22, 2024

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

September 10, 2024

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

August 28, 2024

NeoGenomics Reports Second Quarter 2024 Results

July 28, 2024

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024

July 8, 2024

Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month

June 12, 2024

NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management

May 27, 2024

NeoGenomics Reports First Quarter 2024 Results

April 29, 2024

NeoGenomics Announces Senior Leadership Promotions

April 17, 2024

NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024

April 8, 2024

NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting

March 26, 2024

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report

March 19, 2024

NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference

February 29, 2024

NeoGenomics Reports Fourth Quarter and Full Year 2023 Results

February 19, 2024

NeoGenomics Signs Working with Cancer Pledge in Support of Employees

January 31, 2024

NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024

January 29, 2024

NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

January 1, 2024

NeoGenomics to Appeal Ruling

December 27, 2023

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

December 4, 2023

NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference

November 13, 2023

NeoGenomics Reports Third Quarter 2023 Results

November 5, 2023

NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios

October 23, 2023

NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023

October 16, 2023

NeoGenomics Reports Second Quarter 2023 Results

August 7, 2023

NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer

July 26, 2023

NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023

July 17, 2023

NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors

June 28, 2023

NeoGenomics' RaDaR Assay for Minimal Residual Disease Receives First Commercial Coverage

June 14, 2023

NeoGenomics and German Breast Group Announce New Data Demonstrating Clinical Potential of the RaDaR MRD Assay in HR+/HER2- Breast Cancer

June 4, 2023

NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference

May 31, 2023

NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO

May 29, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 40 decks. Every deck is listed under its year.